OnADose
ASO Keyword Dashboard
Tracking 101 keywords for OnADose in Apple App Store
OnADose tracks 101 keywords (no keywords rank yet; 101 need traction). Key metrics: opportunity 70.7, difficulty 36.9.
Tracked keywords
101
0 ranked • 101 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
70.7
Top keyword: age
Avg difficulty
36.9
Lower scores indicate easier wins
Opportunity leaders
- 66.3
age
Opportunity: 73.0 • Difficulty: 40.4 • Rank —
Competitors: 120
- 66.2
healthcare
Opportunity: 73.0 • Difficulty: 39.9 • Rank —
Competitors: 44
- 68.7
professionals
Opportunity: 73.0 • Difficulty: 41.3 • Rank —
Competitors: 39
- 68.4
reduce
Opportunity: 73.0 • Difficulty: 41.5 • Rank —
Competitors: 82
- 64.7
th
Opportunity: 73.0 • Difficulty: 39.3 • Rank —
Competitors: 64
Unranked opportunities
age
Opportunity: 73.0 • Difficulty: 40.4 • Competitors: 120
healthcare
Opportunity: 73.0 • Difficulty: 39.9 • Competitors: 44
professionals
Opportunity: 73.0 • Difficulty: 41.3 • Competitors: 39
reduce
Opportunity: 73.0 • Difficulty: 41.5 • Competitors: 82
th
Opportunity: 73.0 • Difficulty: 39.3 • Competitors: 64
High competition keywords
us
Total apps: 80,939 • Major competitors: 958
Latest rank: — • Difficulty: 49.7
including
Total apps: 68,459 • Major competitors: 903
Latest rank: — • Difficulty: 49.3
day
Total apps: 63,517 • Major competitors: 869
Latest rank: — • Difficulty: 48.9
life
Total apps: 58,352 • Major competitors: 609
Latest rank: — • Difficulty: 48.4
making
Total apps: 56,539 • Major competitors: 466
Latest rank: — • Difficulty: 48.1
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| range | 69 | 100 | 46 | 77 37,773 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 330 major competitor apps |
| particularly | 71 | 100 | 33 | 55 1,866 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 7 major competitor apps |
| medical | 71 | 100 | 43 | 72 19,219 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 73 major competitor apps |
| used | 68 | 100 | 48 | 79 50,828 competing apps Median installs: 75 Avg rating: 4.0 | — | — | 303 major competitor apps |
| educational | 71 | 100 | 44 | 73 22,216 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 120 major competitor apps |
| treated | 70 | 100 | 29 | 49 841 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 3 major competitor apps |
| age | 73 | 100 | 40 | 66 9,188 competing apps Median installs: 125 Avg rating: 4.2 | — | — | 120 major competitor apps |
| include | 71 | 100 | 43 | 72 19,568 competing apps Median installs: 100 Avg rating: 4.1 | — | — | 156 major competitor apps |
| life | 68 | 100 | 48 | 80 58,352 competing apps Median installs: 125 Avg rating: 4.3 | — | — | 609 major competitor apps |
| including | 68 | 100 | 49 | 81 68,459 competing apps Median installs: 150 Avg rating: 4.1 | — | — | 903 major competitor apps |
| motion | 72 | 100 | 38 | 62 5,366 competing apps Median installs: 175 Avg rating: 4.0 | — | — | 69 major competitor apps |
| products | 71 | 100 | 45 | 74 24,797 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 270 major competitor apps |
| healthcare | 73 | 100 | 40 | 66 9,005 competing apps Median installs: 75 Avg rating: 4.3 | — | — | 44 major competitor apps |
| patients | 72 | 100 | 38 | 63 5,424 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 21 major competitor apps |
| area | 72 | 100 | 42 | 70 15,717 competing apps Median installs: 100 Avg rating: 4.1 | — | — | 120 major competitor apps |
| tool | 69 | 100 | 47 | 78 48,329 competing apps Median installs: 75 Avg rating: 4.1 | — | — | 214 major competitor apps |
| improve | 69 | 100 | 47 | 78 45,441 competing apps Median installs: 100 Avg rating: 4.2 | — | — | 400 major competitor apps |
| professionals | 73 | 100 | 41 | 69 12,758 competing apps Median installs: 50 Avg rating: 4.3 | — | — | 39 major competitor apps |
| preparation | 72 | 100 | 37 | 62 5,118 competing apps Median installs: 50 Avg rating: 4.2 | — | — | 8 major competitor apps |
| joint | 70 | 100 | 32 | 53 1,412 competing apps Median installs: 75 Avg rating: 4.1 | — | — | 9 major competitor apps |
| important | 69 | 100 | 47 | 78 44,178 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 293 major competitor apps |
| reduce | 73 | 100 | 41 | 68 12,211 competing apps Median installs: 100 Avg rating: 4.2 | — | — | 82 major competitor apps |
| training | 70 | 100 | 45 | 74 27,084 competing apps Median installs: 75 Avg rating: 4.3 | — | — | 192 major competitor apps |
| reported | 70 | 100 | 33 | 53 1,442 competing apps Median installs: 100 Avg rating: 4.1 | — | — | 15 major competitor apps |
| reports | 72 | 100 | 42 | 69 13,332 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 67 major competitor apps |
App Description
This app is intended for training use by US healthcare professionals ONLY. Patients should seek a doctor’s advice before making any medical decisions.
OnabotulinumtoxinA Important Safety Information
OnabotulinumtoxinA Indications
Chronic Migraine
-OnabotulinumtoxinA is indicated for the prophylaxis of headaches in adult patients with Chronic Migraine (≥ 15 days per month with headache lasting 4 hours a day or longer).
Limitations of Use
-Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies.
Spasticity
-OnabotulinumtoxinA is indicated for the treatment of spasticity in patients 2 years of age and older.
Limitations of Use
-OnabotulinumtoxinA has not been shown to improve upper extremity functional abilities or range of motion at a joint affected by a fixed contracture.
Cervical Dystonia
-OnabotulinumtoxinA is indicated for the treatment of adults with Cervical Dystonia to reduce the severity of abnormal head position and neck pain associated with Cervical Dystonia.
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of onabotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
Contraindications
-Hypersensitivity to any botulinum toxin preparation or to any of th